Securities fraud litigation history and active cases
Active Cases
1
Pending Settlement
1
Closed
0
Total Settlement
$17M
25-1036 • December 10, 2021
Class Period Start
November 25, 2019
Class Period End
October 15, 2021
PSLRA Deadline
February 8, 2022
Case Allegations
10b5
Statutes of Repose
Nov 25, 2022
Country
United States
Court
Federal Court
Revance Therapeutics, Inc. (RVNC) Class Action Lawsuit (January 2025)Pending Settlement
3:25cv18 • January 3, 2025
Class Period Start
February 29, 2024
Class Period End
February 28, 2025
PSLRA Deadline
March 4, 2025
Case Allegations
10b5
Statutes of Repose
Mar 1, 2027
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
August 28, 2026
Settlement Fund
$17,000,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or acquired Revance Securities (defined below) during the period of February 29, 2024 through the close of the subject Merger on February 6, 2025, inclusive (the “Class Period”), including common stock (CUSIP: 761330109; ticker “RVNC”) and 1.75% fixed coupon Convertible Senior Unsecured Notes (CUSIP: 761330AB5).
Claim Administrator
A.B. Data, Ltd.
P.O. Box 173120
Milwaukee, WI 53217
+1 877-507-1390
[email protected]
Settlement Website
https://revancesecuritiessettlement.com/home/Hearing Date
August 10, 2026
Opt-out Deadline
July 13, 2026
Settlement Note
Download hereProof Of Claim
Download hereDocket History
TOP